Literature DB >> 8734062

Role of proximal electrode position in transvenous ventricular defibrillation.

J Nitta1, D S Khoury.   

Abstract

Transvenous defibrillation lead systems have been demonstrated to reduce operative morbidity and mortality associated with implantation of cardioverter-defibrillators. To determine the best position for the proximal electrode in transvenous systems, defibrillation thresholds were compared for three positions in a single-pathway, two-lead system. Two defibrillation lead electrodes were transvenously inserted into seven dogs. The distal electrode was positioned in the right ventricular apex. The proximal electrode was randomized to one of three positions: (1) the superior (cranial) vena cava (SVC) at the junction of the right atrium, (2) the left innominate vein at the junction of the SVC, or (3) the external jugular vein. Biphasic defibrillation thresholds for converting electrically induced ventricular fibrillation were determined for the three positions of the proximal electrode in each dog. The innominate vein position resulted in the lowest defibrillation threshold (555 +/- 123 V) as compared to the SVC (640 +/- 126 V; p = 0.0612) and the jugular vein (709 +/- 117 V; p = 0.0013). Lead impedance gradually increased with increasing distance between the two shocking electrodes: 58.4 +/- 11.4 omega for SVC, 76.2 +/- 13.8 omega for innominate vein, and 94.9 +/- 10.2 omega for jugular vein proximal lead electrode position (p < 0.05 for all pairwise comparisons). In two-electrode transvenous defibrillation lead systems, positioning the proximal electrode in the left innominate vein produced the lowest defibrillation threshold.

Entities:  

Mesh:

Year:  1996        PMID: 8734062     DOI: 10.1007/bf02660890

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  27 in total

1.  Clinical experience with a tiered-therapy, multiprogrammable antiarrhythmia device.

Authors:  G H Bardy; C Troutman; J E Poole; P J Kudenchuk; G L Dolack; G Johnson; B Hofer
Journal:  Circulation       Date:  1992-05       Impact factor: 29.690

2.  Evaluation of electrode polarity on defibrillation efficacy.

Authors:  G H Bardy; T D Ivey; M D Allen; G Johnson; H L Greene
Journal:  Am J Cardiol       Date:  1989-02-15       Impact factor: 2.778

3.  Implantation of a cardioverter/defibrillator without thoracotomy using a triple electrode system.

Authors:  S Saksena; V Parsonnet
Journal:  JAMA       Date:  1988-01-01       Impact factor: 56.272

4.  Ventricular defibrillation using biphasic waveforms: the importance of phasic duration.

Authors:  A S Tang; S Yabe; J M Wharton; M Dolker; W M Smith; R E Ideker
Journal:  J Am Coll Cardiol       Date:  1989-01       Impact factor: 24.094

5.  Management of complications associated with a first-generation endocardial defibrillation lead system for implantable cardioverter-defibrillators.

Authors:  N G Tullo; S Saksena; R B Krol; A M Mauro; D Kunecz
Journal:  Am J Cardiol       Date:  1990-08-15       Impact factor: 2.778

6.  Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.

Authors:  S Saksena; N G Tullo; R B Krol; A M Mauro
Journal:  Arch Intern Med       Date:  1989-10

7.  Long-term outcome with the automatic implantable cardioverter-defibrillator.

Authors:  R A Winkle; R H Mead; M A Ruder; V A Gaudiani; N A Smith; W S Buch; P Schmidt; T Shipman
Journal:  J Am Coll Cardiol       Date:  1989-05       Impact factor: 24.094

8.  Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.

Authors: 
Journal:  J Am Coll Cardiol       Date:  1994-06       Impact factor: 24.094

9.  Experience with two different nonthoracotomy systems for implantable defibrillator in 170 patients.

Authors:  J S Sra; A Natale; K Axtell; C Maglio; M Jazayeri; S Deshpande; A Dhala; Z Blanck; M Akhtar
Journal:  Pacing Clin Electrophysiol       Date:  1994-11       Impact factor: 1.976

10.  The automatic implantable cardioverter-defibrillator: efficacy, complications, and device failures.

Authors:  F E Marchlinski; B T Flores; A E Buxton; W C Hargrove; V P Addonizio; L W Stephenson; A H Harken; J U Doherty; E W Grogan; M E Josephson
Journal:  Ann Intern Med       Date:  1986-04       Impact factor: 25.391

View more
  2 in total

1.  Pharmacologic enhancement of atrial electrical defibrillation efficacy: role of ibutilide.

Authors:  D S Khoury; M D Assar; H Sun
Journal:  J Interv Card Electrophysiol       Date:  1997-12       Impact factor: 1.900

2.  A systematic evaluation of conventional and novel transvenous pathways for defibrillation.

Authors:  P R Roberts; S Allen; D C Smith; J F Urban; D E Euler; R W Dahl; M J Kallok; J M Morgan
Journal:  J Interv Card Electrophysiol       Date:  1999-10       Impact factor: 1.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.